The Patient Experience of a Paramedic-Pharmacist Referral Pathway for Clinical Medication Reviews
PEPPR
2 other identifiers
observational
132
1 country
1
Brief Summary
This study seeks to understand how patients feel about their medicines before and after receiving a clinical medication review.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2019
CompletedFirst Posted
Study publicly available on registry
May 6, 2019
CompletedStudy Start
First participant enrolled
July 24, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedAugust 12, 2019
August 1, 2019
11 months
May 2, 2019
August 7, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of patients who express a change in emotion relating to how they feel about their medicines, following a pharmacist-led clinical medication review.
1 month
Secondary Outcomes (1)
Patient expressed emotion
1 month
Interventions
Patients who are eligible for this study will have been previously identified as part of the PREFACES project. The pharmacist who has conducted the clinical medication review will obtain verbal permission from the patient to be contacted by the research study team. This will be documented on the referral outcome document that is returned to the YAS clinical team. A member of YAS clinical staff from the PREFACES project will forward the name and residential address of patients who have agreed to be contacted to the research paramedic for this study. A covering letter, participant information sheet, questionnaire and consent form, will be posted to potential participants. A stamped addressed envelope will be included to enable return of the completed booklet at no costs to participants.
Eligibility Criteria
This study will be conducted from a single site (Yorkshire Ambulance Service NHS Trust). YAS staff make around 70-100 falls referral pathways a month in the Leeds area, and after exclusions relating to the PREFACS projects, it is anticipated that around 55 patients per month will be eligible to receive a pharmacist-led clinical medication review and will therefore be eligible for this study, up to a maximum of 550 patients.
You may qualify if:
- Received a pharmacist-led clinical medication review following a falls referral made by a paramedic from Yorkshire Ambulance
- Registered with a GP in the Leeds area
- Has capacity to consent to take part in the study
You may not qualify if:
- Did not receive a pharmacist-led clinical medication review after a Yorkshire Ambulance Service paramedic made a falls referral
- Not registered with a GP in the Leeds area
- Does not have capacity to consent to take part in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yorkshire Ambulance Service NHS Trust
Wakefield, West Yorkshire, WF2 0XQ, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2019
First Posted
May 6, 2019
Study Start
July 24, 2019
Primary Completion
June 30, 2020
Study Completion
June 30, 2020
Last Updated
August 12, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share